3) Immunomodulatory cells such as Tregs, Bregs, and Tfr are significantly increased in OMS subjects, and 4) the expression of exhaustion molecules on immune cells is significantly elevated in the OMS group. The gene discussed is TFRC; the disease is opsoclonus-myoclonus syndrome.